Edwards Lifesciences (EW) Competitors $74.81 +0.88 (+1.19%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends EW vs. SYK, BSX, MDT, BDX, IDXX, RMD, DXCM, STE, PODD, and HOLXShould you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Hologic (HOLX). These companies are all part of the "health care equipment" industry. Edwards Lifesciences vs. Stryker Boston Scientific Medtronic Becton, Dickinson and Company IDEXX Laboratories ResMed DexCom STERIS Insulet Hologic Stryker (NYSE:SYK) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability. Do analysts prefer SYK or EW? Stryker presently has a consensus price target of $405.80, suggesting a potential upside of 11.78%. Edwards Lifesciences has a consensus price target of $79.40, suggesting a potential upside of 6.62%. Given Stryker's stronger consensus rating and higher probable upside, analysts plainly believe Stryker is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stryker 0 Sell rating(s) 3 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.85Edwards Lifesciences 0 Sell rating(s) 15 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has stronger valuation & earnings, SYK or EW? Stryker has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStryker$21.97B6.30$3.17B$9.3338.91Edwards Lifesciences$6.31B6.96$1.40B$6.9310.75 Does the media refer more to SYK or EW? In the previous week, Edwards Lifesciences had 13 more articles in the media than Stryker. MarketBeat recorded 26 mentions for Edwards Lifesciences and 13 mentions for Stryker. Stryker's average media sentiment score of 1.04 beat Edwards Lifesciences' score of 0.52 indicating that Stryker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 10 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is SYK or EW more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Stryker's net margin of 16.34%. Stryker's return on equity of 23.07% beat Edwards Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Stryker16.34% 23.07% 11.04% Edwards Lifesciences 70.82%20.76%15.27% Does the MarketBeat Community prefer SYK or EW? Edwards Lifesciences received 411 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 71.03% of users gave Edwards Lifesciences an outperform vote while only 64.77% of users gave Stryker an outperform vote. CompanyUnderperformOutperformStrykerOutperform Votes92364.77% Underperform Votes50235.23% Edwards LifesciencesOutperform Votes133471.03% Underperform Votes54428.97% Which has more volatility and risk, SYK or EW? Stryker has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Do insiders and institutionals believe in SYK or EW? 77.1% of Stryker shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 5.9% of Stryker shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryStryker beats Edwards Lifesciences on 10 of the 18 factors compared between the two stocks. Ad Wealthpin ProI want to send you my Cash CalendarThis Calendar reveals the EXACT dates that — if everything goes right — anyone can target cash payouts of $125, $415, and even $1,665. (With just a $1,000 starting stake!) Granted, there were smaller wins and those that did not work out and we cannot promise future returns or against losses, but these payouts don’t require any special knowledge or skills. Anyone can set them up with just three clicks in their brokerage account. And the money can be deposited in their account the very next morning after opening the trade. Again, I want to send this Cash Calendar to you completely FREE. All you have to do is join me for my free Cash Calendar training right here. You don’t want to miss this. There is a very special bonus surprise for everyone who attends. Reserve your seat. Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EW vs. The Competition Export to ExcelMetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$43.92B$9.56B$5.02B$19.25BDividend YieldN/A1.35%4.87%3.55%P/E Ratio10.7519.66135.5841.35Price / Sales6.9631.971,118.2617.48Price / Cash26.7122.3940.6621.28Price / Book6.725.514.775.34Net Income$1.40B$182.72M$118.58M$988.53M7 Day Performance1.57%-3.80%-1.65%-3.15%1 Month Performance7.09%-1.33%12.46%-2.01%1 Year Performance0.47%-10.85%31.93%14.41% Edwards Lifesciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWEdwards Lifesciences3.918 of 5 stars$74.81+1.2%$79.40+6.1%+0.9%$44.12B$6.31B10.8019,800High Trading VolumeSYKStryker4.9648 of 5 stars$374.74+0.0%$404.35+7.9%+26.5%$142.86B$21.97B40.1852,000Analyst ForecastBSXBoston Scientific4.3943 of 5 stars$91.10+1.1%$95.52+4.9%+61.8%$134.27B$15.91B75.0248,000Analyst ForecastMDTMedtronic4.9289 of 5 stars$81.91-0.7%$95.27+16.3%+0.5%$105.03B$33.00B25.1495,000Analyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9003 of 5 stars$231.06+2.4%$283.50+22.7%-5.1%$66.80B$20.18B37.9774,000Analyst DowngradeInsider TradeAnalyst RevisionIDXXIDEXX Laboratories4.9773 of 5 stars$433.24+0.3%$539.63+24.6%-23.6%$35.48B$3.84B41.6711,000RMDResMed4.5175 of 5 stars$240.78+0.9%$227.91-5.3%+36.4%$35.35B$4.81B31.599,980Positive NewsDXCMDexCom4.9076 of 5 stars$76.34-1.1%$98.00+28.4%-31.4%$29.82B$3.95B46.229,600STESTERIS4.9332 of 5 stars$213.81-0.2%$262.50+22.8%-3.5%$21.11B$5.14B48.9118,179Positive NewsPODDInsulet4.2395 of 5 stars$265.70-1.4%$267.44+0.7%+28.2%$18.64B$1.70B46.123,000Positive NewsHOLXHologic4.7066 of 5 stars$73.06-0.8%$89.50+22.5%+1.9%$16.58B$4.03B22.147,063Analyst Forecast Related Companies and Tools Related Companies Stryker Alternatives Boston Scientific Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EW) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.